Libtayo sales are being driven by growth in ... The drug has been approved under the brand name Ordspono. Operating expenses have also likely increased in the quarter due to pipeline advancement ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

But it's not just about marketing flair. AR is savings in physical waste-consider virtual try-ons, interactive packaging, and immersive brand experiences that replace brochures, samples ...

Sanofi and Regeneron have reported new data for Libtayo that suggests the drug could be a contender. Overall survival (OS) was 22 months with the combination, compared to 13 months with chemo on ...

Huda Kattan links Meghan and Harry’s donation exit to Palestine stance Shuttling between UAE and Los Angeles, beauty mogul Huda Kattan boasts more than 44m followers and Instagram posts that are ...

Royal Paper, the company behind Earth First, SuperSoft, Platinum, and EcoFirst paper products — including toilet paper, tissues, napkins, and paper towels — has filed for Chapter 11 bankruptcy ...

In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment TARRYTOWN, N.Y. and PARIS, April 18, 2025 ...

In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment TARRYTOWN, N.Y. and PARIS, April 18 ...